# EDGAR Filing Document

**Accession Number:** 0001027263
**File Stem:** 0001752724-25-204751
**Filing Date:** 2025-8
**Character Count:** 56630
**Document Hash:** 5fc791d00a048694685b0b69fc08b291
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-204751.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0001752724-25-204751

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250826

**DATE AS OF CHANGE**: 20250826

**PERIOD START**: 20251231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EQ ADVISORS TRUST
- **CENTRAL INDEX KEY:** 0001027263

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07953
- **FILM NUMBER:** 251255152

**BUSINESS ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
- **BUSINESS PHONE:** 212-554-1234

**MAIL ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 787 TRUST
- **DATE OF NAME CHANGE:** 19961125

## Series and Classes Contracts Data

### EQ/T. Rowe Price Health Sciences Portfolio (Series ID: S000062644)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000203168 | Class IB     |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** EQ Advisors Trust

- **b. Investment Company Act file number:** 811-07953

- **c. CIK number of Registrant:** 0001027263

- **d. LEI of Registrant:** 549300Q691FLN6WHB832

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 1345 Avenue of the Americas

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10105

  - **Telephone number:** 212-554-1234

**Item A.2. Information about the Series.**

- **a. Name of Series:** EQ/T.Rowe Price Health Sciences Portfolio

- **b. EDGAR series identifier (if any):** S000062644

- **c. LEI of Series:** 549300NXA7ED0U1K6106

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-12-31

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $154325300.68

**Total Liabilities:** $1517907.16

**Net Assets:** $152807393.52

**Cash Not Reported:** $1598477.60

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000203168 | 0.07%                | -6.25%               | 4.07%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-565099.60              | $761950.76                                 |
| Month 2  | $-602210.73              | $-9244912.85                               |
| Month 3  | $404844.56               | $5547544.52                                |

### Schedule of Portfolio Investments

| Name                               | Title                                                               | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Apogee Therapeutics, Inc.          | Apogee Therapeutics, Inc.                                           | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9426 | NS      | $409371.18    | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics, Inc.         | Enliven Therapeutics, Inc.                                          | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5463 | NS      | $109587.78    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics plc           | Bicycle Therapeutics plc                                            | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |     23892 | NS      | $166049.40    | 0.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Ionis Pharmaceuticals, Inc.        | Ionis Pharmaceuticals, Inc.                                         | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      8887 | NS      | $351125.37    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp.          | United Therapeutics Corp.                                           | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      1145 | NS      | $329015.75    | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Heron Therapeutics, Inc.           | Heron Therapeutics, Inc.                                            | CUSIP: 427746102<br>LEI: 549300DR2I1DOPD2IX53 | Long             | EC               | CORP              | US        |     30200 | NS      | $62514.00     | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| ORIC Pharmaceuticals, Inc.         | ORIC Pharmaceuticals, Inc.                                          | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     15700 | NS      | $159355.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Madrigal Pharmaceuticals, Inc.     | Madrigal Pharmaceuticals, Inc.                                      | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      2102 | NS      | $636149.28    | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Oscar Health, Inc.                 | Oscar Health, Inc., Class A                                         | CUSIP: 687793109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9124 | NS      | $195618.56    | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Generation Bio Co.                 | Generation Bio Co.                                                  | CUSIP: 37148K100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30137 | NS      | $9646.85      | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics, Inc.          | Kymera Therapeutics, Inc.                                           | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20532 | NS      | $896016.48    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus NV                           | Merus NV                                                            | CUSIP: N/A<br>LEI: 549300W8GPUWU8QNU293       | Long             | EC               | CORP              | NL        |      7366 | NS      | $387451.60    | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                    | Eli Lilly & Co.                                                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     23433 | NS      | $18266726.49  | 11.95%            |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp.                      | Danaher Corp.                                                       | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |     24373 | NS      | $4814642.42   | 3.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp.                      | Stryker Corp.                                                       | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     19380 | NS      | $7667309.40   | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp.                     | Repligen Corp.                                                      | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |      5548 | NS      | $690060.24    | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences, Inc.       | Neurocrine Biosciences, Inc.                                        | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      9114 | NS      | $1145538.66   | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp.            | Boston Scientific Corp.                                             | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |     53071 | NS      | $5700356.11   | 3.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed, Inc.                       | Insmed, Inc.                                                        | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     33932 | NS      | $3414916.48   | 2.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Vera Therapeutics, Inc.            | Vera Therapeutics, Inc., Class A                                    | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19333 | NS      | $455485.48    | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals, Inc.       | Rhythm Pharmaceuticals, Inc.                                        | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |      5511 | NS      | $348240.09    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics, Inc.          | Soleno Therapeutics, Inc.                                           | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |      8915 | NS      | $746898.70    | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Mettler-Toledo International, Inc. | Mettler-Toledo International, Inc.                                  | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |       497 | NS      | $583835.84    | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals, Inc.       | Tarsus Pharmaceuticals, Inc.                                        | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5432 | NS      | $220050.32    | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| ICON plc                           | ICON plc                                                            | CUSIP: N/A<br>LEI: 6354008SRQGEMC4XFI67       | Long             | EC               | CORP              | IE        |      1416 | NS      | $205957.20    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Sartorius AG                       | Sartorius AG (Preference)                                           | CUSIP: N/A<br>LEI: 529900EQV2DY4FOAMU38       | Long             | EC               | CORP              | DE        |      1513 | NS      | $384963.48    | 0.25%             |  |  |  | No            |                  2 | On Loan: No      |
| Entrada Therapeutics, Inc.         | Entrada Therapeutics, Inc.                                          | CUSIP: 29384C108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6665 | NS      | $44788.80     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics, Inc.        | Allogene Therapeutics, Inc.                                         | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61082 | NS      | $69022.66     | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Argenx SE                          | Argenx SE                                                           | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |      9477 | NS      | $5223911.94   | 3.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings, Inc.            | Lantheus Holdings, Inc.                                             | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |      2461 | NS      | $201457.46    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Aura Biosciences, Inc.             | Aura Biosciences, Inc.                                              | CUSIP: 05153U107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7297 | NS      | $45679.22     | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| N/A                                | Revolution Medicines, Inc.                                          | CUSIP: 76155X118<br>LEI: N/A                  | N/A              | DO               |  | US        |      3127 | NS      | $844.29       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics, Inc.        | Viridian Therapeutics, Inc.                                         | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |      7200 | NS      | $100656.00    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Zai Lab Ltd.                       | Zai Lab Ltd.                                                        | CUSIP: 98887Q104<br>LEI: 549300P2UYQ9U5LY1T58 | Long             | EC               | CORP              | KY        |      3468 | NS      | $121275.96    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines, Inc.         | Revolution Medicines, Inc.                                          | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |     20900 | NS      | $768911.00    | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp.          | Blueprint Medicines Corp.                                           | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |      6954 | NS      | $891363.72    | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine, Inc.                | Disc Medicine, Inc.                                                 | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5372 | NS      | $284501.12    | 0.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Sonova Holding AG                  | Sonova Holding AG (Registered)                                      | CUSIP: N/A<br>LEI: 5299004A0QNX7FBNHS61       | Long             | EC               | CORP              | CH        |      2714 | NS      | $808607.47    | 0.53%             |  |  |  | No            |                  2 | On Loan: No      |
| MediWound Ltd.                     | MediWound Ltd.                                                      | CUSIP: N/A<br>LEI: 549300LJKCS74GRYKF90       | Long             | EC               | CORP              | IL        |      3890 | NS      | $75349.30     | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| PROCEPT BioRobotics Corp.          | PROCEPT BioRobotics Corp.                                           | CUSIP: 74276L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10932 | NS      | $629683.20    | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd.            | WaVe Life Sciences Ltd.                                             | CUSIP: N/A<br>LEI: 54930070006GPKFYZ813       | Long             | EC               | CORP              | SG        |     20377 | NS      | $132450.50    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences, Inc.           | Ideaya Biosciences, Inc.                                            | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |      6083 | NS      | $127864.66    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd.              | Roivant Sciences Ltd.                                               | CUSIP: N/A<br>LEI: 549300DL466NY5J6U724       | Long             | EC               | CORP              | BM        |     13100 | NS      | $147637.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Molina Healthcare, Inc.            | Molina Healthcare, Inc.                                             | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |      3516 | NS      | $1047416.40   | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines, Inc.   | Praxis Precision Medicines, Inc.                                    | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6854 | NS      | $288210.70    | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome, Inc.                     | Immunome, Inc.                                                      | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39086 | NS      | $363499.80    | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics, Inc.                 | Cytokinetics, Inc.                                                  | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |      6949 | NS      | $229594.96    | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                | GeneDx Holdings Corp.                                               | CUSIP: 81663L119<br>LEI: N/A                  | N/A              | DO               |  | US        |      3332 | NS      | $219.91       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group, Inc.              | Replimune Group, Inc.                                               | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |     33711 | NS      | $313175.19    | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics, Inc.           | Janux Therapeutics, Inc.                                            | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7679 | NS      | $177384.90    | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Centessa Pharmaceuticals plc       | Centessa Pharmaceuticals plc                                        | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             | EC               | CORP              | GB        |     48807 | NS      | $641323.98    | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical, Inc.    | Ultragenyx Pharmaceutical, Inc.                                     | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     11730 | NS      | $426502.80    | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Revvity, Inc.                      | Revvity, Inc.                                                       | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |      6118 | NS      | $591732.96    | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems, Inc.                | Veeva Systems, Inc., Class A                                        | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |      2354 | NS      | $677904.92    | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicara Therapeutics, Inc.          | Bicara Therapeutics, Inc.                                           | CUSIP: 055477103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22649 | NS      | $210409.21    | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| Nuvalent, Inc.                     | Nuvalent, Inc., Class A                                             | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5824 | NS      | $444371.20    | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Health Services, Inc.    | Universal Health Services, Inc., Class B                            | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |       900 | NS      | $163035.00    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Cabaletta Bio, Inc.                | Cabaletta Bio, Inc.                                                 | CUSIP: 12674W109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6400 | NS      | $9728.00      | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera, Inc.                       | Natera, Inc.                                                        | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8131 | NS      | $1373651.14   | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| BeOne Medicines Ltd.               | BeOne Medicines Ltd.                                                | CUSIP: N/A<br>LEI: 549300JFUK6FRD5MH739       | Long             | EC               | CORP              | CH        |    116155 | NS      | $2186983.23   | 1.43%             |  |  |  | No            |                  2 | On Loan: No      |
| UroGen Pharma Ltd.                 | UroGen Pharma Ltd.                                                  | CUSIP: N/A<br>LEI: 549300C0YCX7CG2G5D50       | Long             | EC               | CORP              | IL        |      3900 | NS      | $53430.00     | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Kyverna Therapeutics, Inc.         | Kyverna Therapeutics, Inc.                                          | CUSIP: 501976104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19761 | NS      | $60666.27     | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Exact Sciences Corp.               | Exact Sciences Corp.                                                | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     14723 | NS      | $782380.22    | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Alignment Healthcare, Inc.         | Alignment Healthcare, Inc.                                          | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25029 | NS      | $350406.00    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Encompass Health Corp.             | Encompass Health Corp.                                              | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |      3258 | NS      | $399528.54    | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca plc                    | AstraZeneca plc                                                     | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     27006 | NS      | $1887179.28   | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor, Inc.                       | Xencor, Inc.                                                        | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     12906 | NS      | $101441.16    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp.                     | McKesson Corp.                                                      | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |       317 | NS      | $232291.26    | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Sensorion SA                       | Sensorion SA                                                        | CUSIP: N/A<br>LEI: 969500P0W8XJ9CGZDP97       | Long             | EC               | CORP              | FR        |    125889 | NS      | $46118.49     | 0.03%             |  |  |  | No            |                  2 | On Loan: —       |
| Summit Therapeutics, Inc.          | Summit Therapeutics, Inc.                                           | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     41526 | NS      | $883673.28    | 0.58%             |  |  |  | No            |                  1 | On Loan: —       |
| CG oncology, Inc.                  | CG oncology, Inc.                                                   | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18568 | NS      | $482768.00    | 0.32%             |  |  |  | No            |                  1 | On Loan: —       |
| Iovance Biotherapeutics, Inc.      | Iovance Biotherapeutics, Inc.                                       | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |     21291 | NS      | $36620.52     | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Kestra Medical Technologies Ltd.   | Kestra Medical Technologies Ltd.                                    | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |      6463 | NS      | $107156.54    | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| MBX Biosciences, Inc.              | MBX Biosciences, Inc.                                               | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18362 | NS      | $209510.42    | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| Annexon, Inc.                      | Annexon, Inc.                                                       | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15220 | NS      | $36528.00     | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cargo Therapeutics, Inc.           | Cargo Therapeutics, Inc.                                            | CUSIP: 14179K101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4333 | NS      | $17851.96     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals, Inc.      | Alnylam Pharmaceuticals, Inc.                                       | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     14152 | NS      | $4614825.68   | 3.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte, Inc.                      | Vaxcyte, Inc.                                                       | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     22851 | NS      | $742886.01    | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                | Ascendis Pharma A/S                                                 | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |     10022 | NS      | $1729797.20   | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                | SomaLogic, Inc.                                                     | CUSIP: 83444K113<br>LEI: N/A                  | N/A              | DO               |  | US        |      1418 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Beam Therapeutics, Inc.            | Beam Therapeutics, Inc.                                             | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17190 | NS      | $292401.90    | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Oruka Therapeutics, Inc.           | Oruka Therapeutics, Inc.                                            | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |      6893 | NS      | $77270.53     | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Agios Pharmaceuticals, Inc.        | Agios Pharmaceuticals, Inc.                                         | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |     16771 | NS      | $557803.46    | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Ginkgo Bioworks Holdings, Inc.     | Ginkgo Bioworks Holdings, Inc., Class A                             | CUSIP: 37611X209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1346 | NS      | $15142.50     | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Cooper Cos., Inc. (The)            | Cooper Cos., Inc. (The)                                             | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     15202 | NS      | $1081774.32   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Verona Pharma plc                  | Verona Pharma plc                                                   | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |     19084 | NS      | $1804964.72   | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics, Inc.          | Axsome Therapeutics, Inc.                                           | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |      1000 | NS      | $104390.00    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health, Inc.              | Cardinal Health, Inc.                                               | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |      4403 | NS      | $739704.00    | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Tenet Healthcare Corp.             | Tenet Healthcare Corp.                                              | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |      8776 | NS      | $1544576.00   | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom, Inc.                       | Dexcom, Inc.                                                        | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |      5431 | NS      | $474071.99    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals, Inc.    | Crinetics Pharmaceuticals, Inc.                                     | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |     16640 | NS      | $478566.40    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics, Inc.         | Celldex Therapeutics, Inc.                                          | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     13023 | NS      | $265018.05    | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Alector, Inc.                      | Alector, Inc.                                                       | CUSIP: 014442107<br>LEI: 549300Z8RQOIY1JMHC25 | Long             | EC               | CORP              | US        |     51854 | NS      | $72595.60     | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas, Inc.                      | Arvinas, Inc.                                                       | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3706 | NS      | $27276.16     | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals, Inc.       | ACADIA Pharmaceuticals, Inc.                                        | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |      3600 | NS      | $77652.00     | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals, Inc.       | Vertex Pharmaceuticals, Inc.                                        | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     13456 | NS      | $5990611.20   | 3.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra, Inc.                     | Penumbra, Inc.                                                      | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |      8876 | NS      | $2277847.88   | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Group (The)                  | Cigna Group (The)                                                   | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |      9924 | NS      | $3280675.92   | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics, Inc.         | Rapport Therapeutics, Inc.                                          | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17648 | NS      | $200657.76    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Climb Bio, Inc.                    | Climb Bio, Inc.                                                     | CUSIP: 28658R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6500 | NS      | $8060.00      | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Legend Biotech Corp.               | Legend Biotech Corp.                                                | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | KY        |     10329 | NS      | $366576.21    | 0.24%             |  |  |  | No            |                  1 | On Loan: —       |
| Avidity Biosciences, Inc.          | Avidity Biosciences, Inc.                                           | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34639 | NS      | $983747.60    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co. Ltd.     | Chugai Pharmaceutical Co. Ltd.                                      | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |     32000 | NS      | $1672164.16   | 1.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Masimo Corp.                       | Masimo Corp.                                                        | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |      3990 | NS      | $671197.80    | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc.                                  | CUSIP: 10950A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     27874 | NS      | $657547.66    | 0.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Akero Therapeutics, Inc.           | Akero Therapeutics, Inc.                                            | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |     16643 | NS      | $888070.48    | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories, Inc.           | IDEXX Laboratories, Inc.                                            | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |      1221 | NS      | $654871.14    | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS TREASURY & AGENCY LEX      | DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT FUND OPEN-END FUND USD | CUSIP: 261908107<br>LEI: 54930067A504FBYASH16 | Long             | STIV             | RF                | US        |    300000 | PA      | $300000.00    | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp.         | Scholar Rock Holding Corp.                                          | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |     29546 | NS      | $1046519.32   | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics, Inc.     | Protagonist Therapeutics, Inc.                                      | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10829 | NS      | $598518.83    | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| INVESCO GOVT AND AGCY LEX          | INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD             | CUSIP: 825252885<br>LEI: O37NHJVF7S22I1ONOU83 | Long             | STIV             | RF                | US        |    706768 | PA      | $706768.25    | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| BeOne Medicines Ltd.               | BeOne Medicines Ltd.                                                | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | CH        |       370 | NS      | $89565.90     | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Metsera, Inc.                      | Metsera, Inc.                                                       | CUSIP: 59267L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7651 | NS      | $217670.95    | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| Helix Acquisition Corp. II         | Helix Acquisition Corp. II, Class A                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | KY        |     11193 | NS      | $119205.45    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals, Inc.       | Rocket Pharmaceuticals, Inc.                                        | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     16956 | NS      | $41542.20     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx, Inc.                      | Arcellx, Inc.                                                       | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6837 | NS      | $450216.45    | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen, Inc.                        | Amgen, Inc.                                                         | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      1126 | NS      | $314390.46    | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics, Inc.            | Quest Diagnostics, Inc.                                             | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |      5847 | NS      | $1050296.61   | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| TFDXX LEX BLACKROCK FED FUND       | BLACKROCK LIQUIDITY FEDFUND OPEN-END FUND USD                       | CUSIP: 09248U700<br>LEI: 549300T8K043VZEOVK74 | Long             | STIV             | RF                | US        |    300000 | PA      | $300000.00    | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Orchestra BioMed Holdings, Inc.    | Orchestra BioMed Holdings, Inc.                                     | CUSIP: 68572M106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9046 | NS      | $24243.28     | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Beta Bionics, Inc.                 | Beta Bionics, Inc.                                                  | CUSIP: 08659B102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3021 | NS      | $43985.76     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics, Inc.           | Spyre Therapeutics, Inc.                                            | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |      9256 | NS      | $138562.32    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare, Inc.               | HCA Healthcare, Inc.                                                | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |      3243 | NS      | $1242393.30   | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health, Inc.              | Elevance Health, Inc.                                               | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |      7746 | NS      | $3012884.16   | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical, Inc.           | Intuitive Surgical, Inc.                                            | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     16440 | NS      | $8933660.40   | 5.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech, Inc.              | Krystal Biotech, Inc.                                               | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      2201 | NS      | $302549.46    | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Lyell Immunopharma, Inc.           | Lyell Immunopharma, Inc.                                            | CUSIP: 55083R203<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4678 | NS      | $41353.52     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie, Inc.                       | AbbVie, Inc.                                                        | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     14765 | NS      | $2740679.30   | 1.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Prelude Therapeutics, Inc.         | Prelude Therapeutics, Inc.                                          | CUSIP: 74065P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10946 | NS      | $8859.69      | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics, Inc.      | Monte Rosa Therapeutics, Inc.                                       | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22383 | NS      | $100947.33    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics, Inc.           | Relay Therapeutics, Inc.                                            | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21592 | NS      | $74708.32     | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.    | Regeneron Pharmaceuticals, Inc.                                     | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      3277 | NS      | $1720425.00   | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.              | Gilead Sciences, Inc.                                               | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     34390 | NS      | $3812819.30   | 2.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology, Inc.           | Sana Biotechnology, Inc.                                            | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38755 | NS      | $105801.15    | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| UnitedHealth Group, Inc.           | UnitedHealth Group, Inc.                                            | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     25081 | NS      | $7824519.57   | 5.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific, Inc.     | Thermo Fisher Scientific, Inc.                                      | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     11699 | NS      | $4743476.54   | 3.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health, Inc.              | Guardant Health, Inc.                                               | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     14660 | NS      | $762906.40    | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics, Inc.       | Structure Therapeutics, Inc.                                        | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |      6989 | NS      | $144951.86    | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Denali Therapeutics, Inc.          | Denali Therapeutics, Inc.                                           | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |     39064 | NS      | $546505.36    | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                          | Sanofi SA                                                           | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     18890 | NS      | $912575.90    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd.                      | Biohaven Ltd.                                                       | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | VG        |     27882 | NS      | $393415.02    | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunocore Holdings plc            | Immunocore Holdings plc                                             | CUSIP: 45258D105<br>LEI: 213800IUE3DFS84BVN18 | Long             | EC               | CORP              | GB        |     12838 | NS      | $402856.44    | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| Pharvaris NV                       | Pharvaris NV                                                        | CUSIP: N/A<br>LEI: 9845003BE146D3B75D32       | Long             | EC               | CORP              | NL        |      9016 | NS      | $158681.60    | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| CVS Health Corp.                   | CVS Health Corp.                                                    | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |     14385 | NS      | $992277.30    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics, Inc.         | Voyager Therapeutics, Inc.                                          | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |     14167 | NS      | $44059.37     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Caris Life Sciences, Inc.          | Caris Life Sciences, Inc.                                           | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |      3857 | NS      | $103059.04    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                             | UCB SA                                                              | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |       961 | NS      | $188989.06    | 0.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Sionna Therapeutics, Inc.          | Sionna Therapeutics, Inc.                                           | CUSIP: 829401108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5395 | NS      | $93603.25     | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Cencora, Inc.                      | Cencora, Inc.                                                       | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |      3992 | NS      | $1197001.20   | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics        | MoonLake Immunotherapeutics, Class A                                | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |     16932 | NS      | $799190.40    | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes plc                       | Alkermes plc                                                        | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | IE        |     19301 | NS      | $552201.61    | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-30

**Name of Applicant:** EQ Advisors Trust

**Signature:** Brian Walsh

**Name of Signer:** Brian Walsh

**Title:** Chief Financial Officer and Treasurer